You are looking for

The latest results of the Euro Health Consumer Index (www.healthpowerhouse.com) further confirm the superiority of Bismarckian social philosophy over the Beveridge approach, at least as far as the patient is concerned. Bismarck countries, characterised by compulsory third party insurance systems, feature as the most consumer friendly health systems from the perspective of the patient and […]

Returning to the daily routine after a long, and hot, summer break is always characterised by mixed feelings. Part wishes the languorous morning routines to carry on whilst other forces bring a refreshed mind optimistic about the challenges ahead. This morning’s bright and early start in Brussels was illuminated by two articles in the Financial […]

The arcane world of credit default swaps may seem a very curious subject to stimulate the mind of a life-long medical technology man. My thoughts turned to these strange and questionable instruments, which appear to be one of the roots of the financial crisis, during a week when they were seldom far from the front […]

Talking about the role of the EU in the developing world EC Director General for Development Stefano Manservisi described the new approach to health development policy on a global level: “From donorship to partnership”. He explained that access to medicine needs to be viewed as not only provision of medicines but rather the ability to […]

Is innovation still affordable with increasingly strained healthcare budgets? How can medical innovations continued to be financed? Panelist of the round table of distinguished speakers Member of the European Parliament Jorgo Chatzimarkakis made a statement which nicely complements the study released by AdvaMed only 2 days ago. He said that innovation does not increase costs […]

An exclusive roundtable hosted by Johnson & Johnson during this year’s Hauptstadtkongress debated the question whether the current healthcare system in Germany should compromise between the need to standardize treatments due to scarce resources and increasingly informed patients demanding the best treatment possible. Although panelists agreed that Germany may be leading in terms of standards […]

The EPC organised on May 6th a policy dialogue with the World Bank on the topic: “Russia in the global economic storm” and presented its latest Economic Report dated March 2009 and available here. The numbers of the World Bank, even though considered by the key note as “educated guesses” are still the best available […]

Brussels, 8 April 2009 – Eucomed welcomes revision of directive 2000/35/EC on Late Payments adopted by the European Commission today strengthening current payment obligations. Association disappointed to see final text considerably watered down compared to initial clear targets. As the voice of the medical technology industry in Europe, Eucomed is extremely pleased to see late […]

From 23 – 25 March 2009, the Drug Information Association (DIA) held its annual EuroMeeting in Berlin. During the presentation by Richard Moore, Institute of Nanotechnology, I learned that prescription drugs prove to be ineffective in 30% – 60% of patients1 and that 16% of the drugs approved in the USA are linked to severe […]